CH417576A - Verfahren zur Herstellung von in 6-Stellung halogenierten 1,2a-Methylen- 6-17a-hydroxy-progesteronestern - Google Patents

Verfahren zur Herstellung von in 6-Stellung halogenierten 1,2a-Methylen- 6-17a-hydroxy-progesteronestern

Info

Publication number
CH417576A
CH417576A CH214862A CH214862A CH417576A CH 417576 A CH417576 A CH 417576A CH 214862 A CH214862 A CH 214862A CH 214862 A CH214862 A CH 214862A CH 417576 A CH417576 A CH 417576A
Authority
CH
Switzerland
Prior art keywords
methylene
hydroxy
preparation
progesterone esters
halogenated
Prior art date
Application number
CH214862A
Other languages
English (en)
Inventor
Rudolf Dr Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH417576A publication Critical patent/CH417576A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH214862A 1961-04-29 1962-02-22 Verfahren zur Herstellung von in 6-Stellung halogenierten 1,2a-Methylen- 6-17a-hydroxy-progesteronestern CH417576A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH29643A DE1158966B (de) 1961-04-29 1961-04-29 Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern

Publications (1)

Publication Number Publication Date
CH417576A true CH417576A (de) 1966-07-31

Family

ID=7431494

Family Applications (1)

Application Number Title Priority Date Filing Date
CH214862A CH417576A (de) 1961-04-29 1962-02-22 Verfahren zur Herstellung von in 6-Stellung halogenierten 1,2a-Methylen- 6-17a-hydroxy-progesteronestern

Country Status (6)

Country Link
US (1) US3234093A (de)
BE (1) BE616989A (de)
BR (1) BR6238435D0 (de)
CH (1) CH417576A (de)
DE (1) DE1158966B (de)
GB (1) GB973908A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050218A (de) * 1964-10-13
US3401163A (en) * 1965-10-21 1968-09-10 Squibb & Sons Inc Preparation of methylene steroids
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
DE2345377A1 (de) * 1973-09-06 1975-03-20 Schering Ag Pharmazeutische zubereitung i
GB1570524A (en) * 1976-03-11 1980-07-02 Unilever Ltd Cosmetic
DE2712861C2 (de) * 1977-03-21 1986-02-27 Schering AG, 1000 Berlin und 4709 Bergkamen 17-Acetoxy-6-chlor-15β-hydroxy-1α,2α-methylen-4,6-pregnadien-3,20-dion, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE3331824A1 (de) * 1983-09-01 1985-03-21 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von 17(alpha)-acyloxy-6-chlor-1(alpha),2(alpha)-methylen-3,20-dionen
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate
US5468104A (en) 1994-08-10 1995-11-21 Fatigue Technology, Inc. Wall nut assembly
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US20040024230A1 (en) * 2002-04-29 2004-02-05 Boehringer Ingelheim International Gmbh Synthesis of cyproterone acetate
EP1359154A1 (de) * 2002-04-29 2003-11-05 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Weitere Verfahren zur Herstellung von Cyproteron Azetat
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
EP2278880B1 (de) 2008-04-09 2012-10-10 Pherin Pharmaceuticals, Inc. Steroidbehandlung für hitzewallungen
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
DK2925725T3 (en) 2012-12-03 2017-01-16 Pfizer androgen receptor modulators

Also Published As

Publication number Publication date
US3234093A (en) 1966-02-08
BR6238435D0 (pt) 1973-05-24
GB973908A (en) 1964-11-04
DE1158966B (de) 1963-12-12
BE616989A (fr) 1962-10-29

Similar Documents

Publication Publication Date Title
CH412918A (de) Verfahren zur Herstellung von 1,8-Naphthyridinen
CH417576A (de) Verfahren zur Herstellung von in 6-Stellung halogenierten 1,2a-Methylen- 6-17a-hydroxy-progesteronestern
CH420067A (de) Verfahren zur Herstellung von ortho-Alkylphenolen
CH457473A (de) Verfahren zur Herstellung von 9,10-Dihydroergovalin
CH376898A (de) Verfahren zur Herstellung von in 6-Stellung substituierten 2,3-Dimethoxy-5-methyl-benzohydrochinonen-(1,4) bzw.-benzochinonen-(1,4)
CH425813A (de) Verfahren zur Herstellung von Trialkalinitrilotriacetat
AT255031B (de) Verfahren zur Herstellung von 1-Glykosyl-6-azauracilen
CH419146A (de) Verfahren zur Herstellung von 3-Phenyl-7-pyrazolyl-cumarinen
CH420186A (de) Verfahren zur Herstellung von 2-Amino-benzophenonen
CH420185A (de) Verfahren zur Herstellung von 5-Mononucleotiden
AT239438B (de) Verfahren zur Herstellung von α-Aminobenzylpenicillin
AT241687B (de) Verfahren zur Herstellung von α-Aminobenzylpenicillin
CH421935A (de) Verfahren zur Herstellung von 2-Halogen- und 2,4-Dihalogen-alkylphenylcarbamaten
CH421120A (de) Verfahren zur Herstellung von Sulfapyrimidinen
CH413836A (de) Verfahren zur Herstellung von Distilbazolen
CH420135A (de) Verfahren zur Herstellung von 16-Alkylpregnenen
CH397715A (de) Verfahren zur Herstellung von 2,5-Diarylaminoterephthalsäuren
CH404652A (de) Verfahren zur Herstellung von 1,4-3-Ketosteroiden
CH427793A (de) Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
CH401026A (de) Verfahren zur Herstellung von B-Ketoamiden
CH432487A (de) Verfahren zur Herstellung von Mononitro-1,3,5-trialkylbenzol
CH415675A (de) Verfahren zur Herstellung von 4-Methyl-6-isobutenyl-pyron-(2)
CH407086A (de) Verfahren zur Herstellung von 1,2,3,4-Tetraalkyl-anthrachinon-8-carbonsäuren
CH422788A (de) Verfahren zur Herstellung von 6-(5'-Diäthylaminopentyl-2'-amino)-5,8-dimethoxy-chinolinen
CH401949A (de) Verfahren zur Herstellung von 1-Alkyl-1-alkoxy-3-arylharnstoff